Zimmer Biomet - ZBH Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $139.39
Forecasted Upside: 16.40%
Number of Analysts: 15
Breakdown:
1 Sell Ratings
9 Hold Ratings
5 Buy Ratings
0 Strong Buy Ratings

^$119.75 As of 04/25/2024 01:00 AM ET

▼ -1.42 (-1.17%)

1 month | 3 months | 12 months

Get New Zimmer Biomet Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ZBH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZBH

^$139.39

▲ +16.40% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for Zimmer Biomet in the last 3 months. The average price target is $139.39, with a high forecast of $172.00 and a low forecast of $120.00. The average price target represents a 16.40% upside from the last price of $119.75.

Current Consensus is Hold

The current consensus among 15 contributing investment analysts is to hold stock in Zimmer Biomet. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

11/2/2022

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

1/31/2023

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

5/1/2023

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

7/30/2023

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

10/28/2023

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

1/26/2024

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

3/26/2024

0 strong buy ratings
5 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

4/25/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/4/2024	Evercore ISI	Boost Target	In-Line ➝ In-Line	$125.00 ➝ $130.00	Low
4/3/2024	Citigroup	Boost Target	Neutral ➝ Neutral	$134.00 ➝ $140.00	Low
2/23/2024	Canaccord Genuity Group	Reiterated Rating	Hold ➝ Hold	$130.00	Low
2/12/2024	Barclays	Boost Target	Underweight ➝ Underweight	$120.00 ➝ $130.00	Low
2/9/2024	Truist Financial	Boost Target	Hold ➝ Hold	$133.00 ➝ $135.00	Low
2/9/2024	JPMorgan Chase & Co.	Boost Target	Neutral ➝ Neutral	$115.00 ➝ $125.00	Low
2/9/2024	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$140.00	Low
1/12/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$134.00 ➝ $140.00	Low
1/4/2024	Evercore ISI	Downgrade	Outperform ➝ Inline	$135.00 ➝ $125.00	Low
1/3/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$133.00 ➝ $137.00	Low
12/22/2023	Truist Financial	Boost Target	Hold ➝ Hold	$115.00 ➝ $133.00	Low
12/4/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$120.00 ➝ $125.00	Low
11/13/2023	JMP Securities	Lower Target	Market Outperform ➝ Market Outperform	$160.00 ➝ $140.00	Low
11/9/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$160.00 ➝ $133.00	Low
11/8/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$140.00 ➝ $120.00	Low
11/8/2023	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$146.00 ➝ $115.00	Low
10/20/2023	Roth Mkm	Initiated Coverage	Neutral	$120.00	Low
10/2/2023	Citigroup	Lower Target	Neutral ➝ Neutral	$146.00 ➝ $125.00	Low
8/28/2023	BTIG Research	Upgrade	Neutral ➝ Buy	$139.00	Low
8/2/2023	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$157.00	Low
8/2/2023	JMP Securities	Reiterated Rating	Market Outperform ➝ Market Outperform	$160.00	Low
8/2/2023	Morgan Stanley	Reiterated Rating	Equal Weight ➝ Equal Weight	$140.00	N/A
8/2/2023	Truist Financial	Lower Target	Hold ➝ Hold	$153.00 ➝ $148.00	N/A
8/2/2023	UBS Group	Boost Target		$116.00 ➝ $125.00	Low
8/2/2023	Barclays	Boost Target	Underweight ➝ Underweight	$116.00 ➝ $120.00	Low
7/19/2023	Truist Financial	Boost Target		$147.00 ➝ $153.00	Low
5/18/2023	22nd Century Group	Reiterated Rating	Maintains		Low
5/18/2023	888	Reiterated Rating	Maintains		Low
5/18/2023	Stifel Nicolaus	Boost Target		$160.00 ➝ $165.00	Low
5/18/2023	Truist Financial	Lower Target		$153.00 ➝ $147.00	Low
5/4/2023	Barclays	Boost Target		$105.00 ➝ $116.00	Low
5/3/2023	58.com	Reiterated Rating	Maintains		Low
5/3/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$121.00 ➝ $147.00	Low
5/3/2023	Truist Financial	Boost Target		$137.00 ➝ $153.00	Low
5/3/2023	FIG Partners	Upgrade	Neutral		Low
5/3/2023	Bank of America	Upgrade	Underperform ➝ Neutral		Low
5/3/2023	Royal Bank of Canada	Boost Target		$141.00 ➝ $156.00	Low
5/3/2023	Raymond James	Boost Target		$144.00 ➝ $160.00	Low
5/3/2023	Robert W. Baird	Boost Target		$145.00 ➝ $172.00	Low
5/3/2023	JMP Securities	Boost Target		$145.00 ➝ $160.00	Low
5/3/2023	Sanford C. Bernstein	Boost Target		$136.00 ➝ $152.00	Low
4/11/2023	Evercore ISI	Upgrade	In-Line ➝ Outperform	$135.00 ➝ $148.00	Low
3/31/2023	Jefferies Financial Group	Upgrade	Underperform ➝ Hold	$115.00 ➝ $130.00	Low
3/28/2023	UBS Group	Initiated Coverage	Sell	$112.00	Low
3/9/2023	Piper Sandler	Upgrade	Neutral ➝ Overweight	$135.00 ➝ $145.00	Low
2/7/2023	JMP Securities	Reiterated Rating	Market Outperform	$145.00	Low
2/6/2023	Loop Capital	Boost Target		$125.00 ➝ $140.00	Low
2/6/2023	Oppenheimer	Boost Target	Outperform	$120.00 ➝ $142.00	Low
2/6/2023	Morgan Stanley	Boost Target	Equal Weight	$135.00 ➝ $140.00	Low
2/6/2023	Truist Financial	Boost Target	Hold	$135.00 ➝ $137.00	Low
2/6/2023	Robert W. Baird	Boost Target		$133.00 ➝ $145.00	Low
2/3/2023	Piper Sandler	Boost Target		$130.00 ➝ $135.00	Low
1/9/2023	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$125.00 ➝ $141.00	Low
1/6/2023	Morgan Stanley	Boost Target	Equal Weight	$120.00 ➝ $135.00	Low
1/5/2023	Piper Sandler	Boost Target		$120.00 ➝ $130.00	Low
1/5/2023	Raymond James	Upgrade	Market Perform ➝ Outperform	$144.00	N/A
1/3/2023	Evercore ISI	Downgrade	Outperform ➝ Inline	$130.00	Low
12/20/2022	Truist Financial	Boost Target	Hold	$120.00 ➝ $135.00	Low
12/12/2022	Citigroup	Boost Target	Neutral	$116.00 ➝ $130.00	Low
11/23/2022	Wells Fargo & Company	Upgrade	Underweight ➝ Equal Weight	$116.00 ➝ $124.00	Low
11/3/2022	Royal Bank of Canada	Lower Target	Sector Perform	$128.00 ➝ $125.00	Low
11/3/2022	Citigroup	Lower Target	Neutral	$119.00 ➝ $116.00	Low
10/17/2022	Barclays	Initiated Coverage	Underweight	$104.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Underperform	$95.00	Low
8/3/2022	Morgan Stanley	Boost Target	Equal Weight	$115.00 ➝ $120.00	Low
8/3/2022	Citigroup	Boost Target		$114.00 ➝ $119.00	Low
8/2/2022	Piper Sandler	Lower Target		$130.00 ➝ $120.00	Low
7/22/2022	Truist Financial	Lower Target		$115.00	Low
7/18/2022	Stifel Nicolaus	Lower Target		$140.00 ➝ $120.00	Low
7/15/2022	Morgan Stanley	Lower Target	Equal Weight	$132.00 ➝ $115.00	Low
5/27/2022	Needham & Company LLC	Downgrade	Buy ➝ Hold		Low
5/17/2022	Citigroup	Lower Target	NA	$135.00 ➝ $125.00	High
5/4/2022	Truist Financial	Lower Target		$142.00 ➝ $131.00	High
5/3/2022	Stifel Nicolaus	Boost Target		$130.00 ➝ $140.00	High
4/13/2022	Truist Financial	Downgrade	Buy ➝ Hold	$128.00 ➝ $142.00	Low
4/1/2022	Citigroup	Downgrade	Buy ➝ Neutral	$125.15 ➝ $135.00	Medium
3/21/2022	The Goldman Sachs Group	Lower Target	Buy	$179.00 ➝ $155.00	Low
3/2/2022	Loop Capital	Downgrade	Buy ➝ Hold	$130.00	Medium
3/1/2022	Bank of America	Initiated Coverage	Underperform ➝ Underperform	$120.00	Medium
2/9/2022	Loop Capital	Lower Target	Buy	$165.00 ➝ $140.00	Low
2/8/2022	Citigroup	Lower Target	Buy	$150.00 ➝ $129.00	High
2/8/2022	Stifel Nicolaus	Lower Target	Buy	$178.00 ➝ $130.00	High
2/8/2022	JPMorgan Chase & Co.	Lower Target	Neutral	$150.00 ➝ $114.00	High
2/8/2022	Royal Bank of Canada	Lower Target	Sector Perform	$140.00 ➝ $125.00	High
2/8/2022	Truist Financial	Lower Target	Buy	$145.00 ➝ $128.00	High
2/8/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$140.00 ➝ $121.00	High
2/8/2022	Wells Fargo & Company	Lower Target	Underweight	$124.00 ➝ $111.00	High
2/8/2022	JMP Securities	Lower Target	Outperform	$175.00 ➝ $145.00	High
2/8/2022	Canaccord Genuity Group	Downgrade	Buy ➝ Hold	$165.00 ➝ $125.00	High
2/8/2022	Needham & Company LLC	Lower Target	Buy	$155.00 ➝ $143.00	High
2/8/2022	SVB Leerink	Lower Target	Outperform	$150.00 ➝ $135.00	High
2/7/2022	Piper Sandler	Lower Target		$135.00 ➝ $110.00	High
2/2/2022	UBS Group	Downgrade	Buy ➝ Neutral	$172.00 ➝ $130.00	Medium
1/21/2022	Needham & Company LLC	Lower Target	Buy	$158.00 ➝ $155.00	Low
1/19/2022	Wells Fargo & Company	Downgrade	Equal Weight ➝ Underweight	$170.00 ➝ $124.00	Medium
1/10/2022	Mizuho	Downgrade	Buy ➝ Neutral		Low
1/10/2022	BTIG Research	Downgrade	Buy ➝ Neutral		Low
1/7/2022	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$165.00 ➝ $145.00	Low
1/4/2022	Piper Sandler	Downgrade	Overweight ➝ Neutral	$185.00 ➝ $135.00	Medium
12/21/2021	Truist Financial	Lower Target	Buy	$175.00 ➝ $145.00	High
12/9/2021	Royal Bank of Canada	Initiated Coverage	Sector Perform	$140.00	Medium
12/9/2021	Needham & Company LLC	Downgrade	Strong-Buy ➝ Buy	$175.00 ➝ $158.00	High
12/6/2021	Loop Capital	Initiated Coverage	Buy	$165.00	High
11/23/2021	Argus	Downgrade	Buy ➝ Hold		Medium
11/5/2021	JMP Securities	Lower Target	Market Outperform	$195.00 ➝ $175.00	High
11/5/2021	Jefferies Financial Group	Lower Target	Buy	$200.00 ➝ $175.00	High
11/5/2021	Citigroup	Lower Target	Buy	$188.00 ➝ $175.00	High
11/5/2021	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$160.00 ➝ $140.00	High
11/5/2021	BTIG Research	Lower Target	Positive ➝ Buy	$173.00 ➝ $161.00	High
11/4/2021	Piper Sandler	Lower Target	Overweight	$195.00 ➝ $185.00	High
10/22/2021	SVB Leerink	Reiterated Rating	Outperform		High
10/5/2021	Barclays	Lower Target	Overweight	$210.00 ➝ $186.00	Low
10/1/2021	Citigroup	Lower Target	Buy	$200.00 ➝ $188.00	Medium
9/14/2021	Robert W. Baird	Reiterated Rating	Buy		High
9/14/2021	Raymond James	Initiated Coverage	Market Perform		High
8/4/2021	SVB Leerink	Lower Target	Outperform	$205.00 ➝ $196.00	High
8/4/2021	Oppenheimer	Lower Target	Outperform	$195.00 ➝ $190.00	High
8/3/2021	Stifel Nicolaus	Lower Target	Positive ➝ Buy	$190.00 ➝ $185.00	High
5/25/2021	Barclays	Initiated Coverage	Overweight	$210.00	Low
5/17/2021	JMP Securities	Boost Target	Market Outperform	$180.00 ➝ $195.00	N/A
5/11/2021	JMP Securities	Boost Target	Outperform	$180.00 ➝ $195.00	High
5/5/2021	Truist Financial	Boost Target		$174.00 ➝ $188.00	Low
5/5/2021	Raymond James	Boost Target	Strong-Buy	$187.00 ➝ $200.00	Low
5/5/2021	SVB Leerink	Boost Target	Outperform	$200.00 ➝ $205.00	Low
5/5/2021	Oppenheimer	Boost Target	Outperform	$185.00 ➝ $195.00	Low
4/15/2021	Northland Securities	Upgrade	Market Perform ➝ Outperform	$165.00 ➝ $200.00	High
4/9/2021	Northland Securities	Upgrade	Market Perform ➝ Outperform		High
3/8/2021	Oppenheimer	Boost Target	Outperform	$173.00 ➝ $185.00	Medium
3/1/2021	Wells Fargo & Company	Boost Target	Overweight	$176.00 ➝ $183.00	Low
2/8/2021	Morgan Stanley	Boost Target	Overweight	$170.00 ➝ $180.00	Low
2/8/2021	Raymond James	Boost Target	Strong-Buy	$170.00 ➝ $187.00	Low
2/8/2021	Wells Fargo & Company	Boost Target	Overweight	$165.00 ➝ $176.00	Low
2/8/2021	SVB Leerink	Boost Target	Positive ➝ Outperform	$185.00 ➝ $190.00	Low
2/8/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$146.00 ➝ $160.00	Low
2/5/2021	Needham & Company LLC	Boost Target	Strong-Buy	$185.00 ➝ $192.00	Low
2/5/2021	Oppenheimer	Initiated Coverage	Buy	$173.00	Low
2/5/2021	Piper Sandler	Boost Target	Overweight	$185.00 ➝ $195.00	Medium
1/27/2021	JMP Securities	Boost Target	Outperform	$165.00 ➝ $180.00	High
1/25/2021	BTIG Research	Boost Target	Buy	$160.00 ➝ $173.00	Medium
1/8/2021	Piper Sandler	Boost Target	Overweight	$160.00 ➝ $185.00	Low
1/6/2021	Truist Financial	Boost Target		$152.00 ➝ $174.00	N/A
1/4/2021	Evercore ISI	Upgrade	In-Line ➝ Outperform	$175.00	N/A
12/24/2020	Argus	Boost Target	Buy	$160.00 ➝ $170.00	N/A
12/24/2020	Raymond James	Reiterated Rating	Buy	$170.00	N/A
12/18/2020	Needham & Company LLC	Boost Target	Strong-Buy	$168.00 ➝ $185.00	Low
12/15/2020	Morgan Stanley	Boost Target	Overweight	$150.00 ➝ $170.00	Low
12/15/2020	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		High
12/14/2020	SVB Leerink	Boost Target	Outperform	$167.00 ➝ $175.00	Low
11/9/2020	Oppenheimer	Boost Target	Outperform	$150.00 ➝ $155.00	Medium
11/9/2020	Credit Suisse Group	Boost Target	Underperform	$99.00 ➝ $106.00	High
11/9/2020	SVB Leerink	Boost Target	Outperform	$160.00 ➝ $167.00	High
10/27/2020	Cowen	Boost Target	Positive ➝ Market Perform	$130.00 ➝ $150.00	High
10/20/2020	Northland Securities	Initiated Coverage	Market Perform	$150.00	Low
10/12/2020	Raymond James	Boost Target	Strong-Buy	$150.00 ➝ $170.00	Low
10/5/2020	SVB Leerink	Boost Target	Outperform	$153.00 ➝ $160.00	Medium
9/11/2020	Wolfe Research	Initiated Coverage	Outperform	$174.00	Low
9/4/2020	Argus	Boost Target		$145.00 ➝ $160.00	Low
8/18/2020	Morgan Stanley	Reiterated Rating	Buy	$150.00	Medium
8/5/2020	Credit Suisse Group	Reiterated Rating	Sell	$99.00	Low
8/5/2020	Morgan Stanley	Boost Target	Overweight	$140.00 ➝ $150.00	Low
8/5/2020	Oppenheimer	Boost Target	Outperform	$138.00 ➝ $150.00	Medium
8/5/2020	SVB Leerink	Boost Target	Outperform	$146.00 ➝ $153.00	Medium
8/5/2020	Raymond James	Boost Target	Strong-Buy	$140.00 ➝ $150.00	Low
8/5/2020	Citigroup	Boost Target	Buy	$140.00 ➝ $155.00	Low
8/4/2020	Needham & Company LLC	Initiated Coverage	Strong-Buy	$148.00 ➝ $162.00	Low
8/4/2020	BTIG Research	Reiterated Rating	Buy	$139.00	Medium
8/4/2020	Oppenheimer	Reiterated Rating	Buy	$138.00	Medium
7/15/2020	SVB Leerink	Boost Target	Outperform	$136.00 ➝ $146.00	High
5/28/2020	Oppenheimer	Initiated Coverage	Buy	$138.00	Low
5/18/2020	JMP Securities	Lower Target	Positive ➝ Outperform	$175.00 ➝ $150.00	High
5/12/2020	UBS Group	Lower Target	Buy	$180.00 ➝ $165.00	High
5/12/2020	Stifel Nicolaus	Boost Target	Buy	$111.00 ➝ $130.00	High
5/12/2020	SunTrust Banks	Boost Target	Buy	$125.00 ➝ $132.00	High
5/12/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$160.00 ➝ $146.00	High
5/12/2020	Wells Fargo & Company	Boost Target	Overweight	$124.00 ➝ $132.00	High
5/12/2020	SVB Leerink	Boost Target	Outperform	$130.00 ➝ $136.00	High
5/12/2020	Raymond James	Boost Target	Strong-Buy	$136.00 ➝ $140.00	High
5/12/2020	Citigroup	Boost Target	Buy	$125.00 ➝ $140.00	High
5/11/2020	Oppenheimer	Lower Target	Outperform	$141.00 ➝ $138.00	High
5/11/2020	Wells Fargo & Company	Reiterated Rating	Buy		High
5/11/2020	Piper Sandler	Lower Target	In-Line ➝ Overweight	$175.00 ➝ $160.00	High
5/11/2020	Needham & Company LLC	Lower Target	Strong-Buy	$153.00 ➝ $148.00	Medium
4/28/2020	Oppenheimer	Lower Target	Outperform	$175.00 ➝ $141.00	Medium
4/28/2020	Guggenheim	Downgrade	Buy ➝ Neutral		Medium
4/19/2020	Evercore ISI	Downgrade	Outperform ➝ In-Line		Medium
4/13/2020	Raymond James	Lower Target	Strong-Buy	$190.00 ➝ $136.00	Low
4/7/2020	SVB Leerink	Boost Target	Outperform	$121.00 ➝ $130.00	High
4/7/2020	SunTrust Banks	Lower Target	Buy	$179.00 ➝ $125.00	High
4/7/2020	BTIG Research	Lower Target	Buy	$170.00 ➝ $130.00	Low
4/7/2020	Needham & Company LLC	Lower Target	Strong-Buy	$189.00 ➝ $153.00	High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$175.00 ➝ $140.00	Low
3/27/2020	Citigroup	Lower Target	Buy	$168.00 ➝ $125.00	High
3/25/2020	SVB Leerink	Lower Target	Outperform	$181.00 ➝ $121.00	High
3/24/2020	Stifel Nicolaus	Lower Target	Buy	$180.00 ➝ $93.00	High
3/6/2020	Credit Suisse Group	Lower Target	Outperform	$125.00 ➝ $115.00	High
3/4/2020	Citigroup	Initiated Coverage	Buy	$168.00	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$177.00	Low
2/6/2020	JMP Securities	Reiterated Rating	Average ➝ Outperform	$175.00	Low
2/5/2020	Oppenheimer	Boost Target		$165.00 ➝ $175.00	Low
2/5/2020	Robert W. Baird	Boost Target	Outperform	$161.00 ➝ $172.00	Low
2/5/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$144.00 ➝ $160.00	Low
2/5/2020	Credit Suisse Group	Boost Target	Underperform	$120.00 ➝ $125.00	Low
2/5/2020	BTIG Research	Reiterated Rating	Buy	$170.00	Low
2/5/2020	Morgan Stanley	Boost Target	Overweight	$170.00 ➝ $175.00	Low
2/5/2020	Raymond James	Boost Target	Positive ➝ Strong-Buy	$170.00 ➝ $190.00	Low
2/4/2020	Piper Sandler	Boost Target	Overweight	$170.00 ➝ $175.00	Low
2/4/2020	Needham & Company LLC	Reiterated Rating	Strong-Buy	$187.00 ➝ $189.00	High
1/10/2020	Wells Fargo & Company	Boost Target	Overweight	$165.00 ➝ $170.00	Medium
1/7/2020	SunTrust Banks	Initiated Coverage	Buy	$179.00	Medium
1/7/2020	Piper Sandler	Upgrade	Neutral ➝ Overweight	$140.00 ➝ $170.00	Low
1/7/2020	Piper Sandler Companies	Upgrade	Neutral ➝ Overweight	$140.00 ➝ $170.00	Low
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$108.00	Low
1/2/2020	Citigroup	Upgrade	Neutral ➝ Buy		Low
12/19/2019	Needham & Company LLC	Boost Target	Strong-Buy	$170.00 ➝ $187.00	Low
12/17/2019	Morgan Stanley	Boost Target	Overweight	$150.00 ➝ $170.00	Low
12/12/2019	Wells Fargo & Company	Boost Target	Overweight	$158.00 ➝ $165.00	Low
12/9/2019	Wells Fargo & Company	Reiterated Rating	Buy		Medium
12/4/2019	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$160.00 ➝ $170.00	High
11/6/2019	Royal Bank of Canada	Boost Target	Outperform	$145.00 ➝ $155.00	Low
11/6/2019	Raymond James	Boost Target	Outperform	$150.00 ➝ $160.00	Medium
11/6/2019	SVB Leerink	Boost Target	Outperform	$155.00 ➝ $160.00	Medium
11/5/2019	Needham & Company LLC	Reiterated Rating	Buy	$170.00	Medium
10/7/2019	BTIG Research	Upgrade	Neutral ➝ Buy	$158.00	Low
9/23/2019	Cowen	Set Target	Buy	$140.00	Medium
9/18/2019	Needham & Company LLC	Reiterated Rating	Buy	$170.00	Medium
9/17/2019	Stifel Nicolaus	Set Target	Buy	$155.00	Low
9/16/2019	BTIG Research	Reiterated Rating	Hold		Low
9/9/2019	Wells Fargo & Company	Boost Target	Outperform	$150.00 ➝ $158.00	Medium
8/12/2019	Argus	Upgrade	Hold ➝ Buy	$160.00	Low
8/2/2019	Citigroup	Boost Target	Buy	$146.00 ➝ $158.00	Low
7/30/2019	Barclays	Upgrade	Underweight ➝ Equal Weight	$117.00 ➝ $140.00	Low
7/29/2019	Oppenheimer	Boost Target	Outperform	$135.00 ➝ $150.00	Low
7/29/2019	Morgan Stanley	Boost Target	Overweight	$143.00 ➝ $150.00	Low
7/29/2019	Wells Fargo & Company	Boost Target	Outperform	$143.00 ➝ $150.00	Low
7/29/2019	Raymond James	Boost Target	Outperform	$145.00 ➝ $150.00	Low
7/29/2019	Credit Suisse Group	Boost Target	Underperform	$101.00 ➝ $120.00	Low
7/29/2019	Jefferies Financial Group	Boost Target	Buy	$150.00 ➝ $167.00	Low
7/29/2019	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$132.00 ➝ $154.00	Low
7/26/2019	Cowen	Set Target	Hold	$140.00	N/A
6/11/2019	Sanford C. Bernstein	Upgrade	Underperform ➝ Market Perform	$121.71	Low
4/26/2019	Cantor Fitzgerald	Set Target	Buy	$135.00	Low

(Data available from 4/26/2019 forward)

News Sentiment Rating

1.20 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

21 very positive mentions
4 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

9/29/2023

10 very positive mentions
5 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

10/29/2023

16 very positive mentions
13 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

11/28/2023

14 very positive mentions
9 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

12/28/2023

26 very positive mentions
8 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

1/27/2024

32 very positive mentions
35 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

2/26/2024

24 very positive mentions
6 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/27/2024

23 very positive mentions
10 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/26/2024

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Negative

No negative mentions tracked during this time.

Positive

markets.businessinsider.com
16 hours ago
Oppenheimer Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
americanbankingnews.com
4/25/2024
Zimmer Biomet (ZBH) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com
4/24/2024
Q1 2024 EPS Estimates for Zimmer Biomet Holdings, Inc. Raised by Zacks Research (NYSE:ZBH)
americanbankingnews.com
4/24/2024
Q3 2024 EPS Estimates for Zimmer Biomet Holdings, Inc. Increased by Analyst (NYSE:ZBH)
marketbeat.com
4/22/2024
Intuitive Surgical Leads the Robotic Surgery Movement (ZBH)

Very Positive

marketbeat.com
10 hours ago
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Sandhill Capital Partners LLC
marketbeat.com
4/24/2024
Illinois Municipal Retirement Fund Has $8.05 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com
4/24/2024
Q1 2024 EPS Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Raised by Zacks Research
marketbeat.com
4/23/2024
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Handelsbanken Fonder AB
marketbeat.com
4/23/2024
Q3 2024 EPS Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Lifted by Analyst

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $119.75

$118.77

$121.35

50 Day Range

MA: $126.09

$119.41

$132.61

52 Week Range

Now: $119.75

$102.00

$149.25

Volume

1,078,771 shs

Average Volume

1,063,875 shs

Market Capitalization

$24.60 billion

P/E Ratio

24.49

Dividend Yield

0.79%

Beta

1.01

Frequently Asked Questions

What sell-side analysts currently cover shares of Zimmer Biomet?: The following sell-side analysts have issued stock ratings on Zimmer Biomet in the last year: 22nd Century Group, Inc., 58.com Inc., 888 Holdings plc, Bank of America Co., Barclays PLC, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, FIG Partners, JMP Securities, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Raymond James, Robert W. Baird, Roth Mkm, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, TheStreet, Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for ZBH.
What is the current price target for Zimmer Biomet?: 18 Wall Street analysts have set twelve-month price targets for Zimmer Biomet in the last year. Their average twelve-month price target is $139.39, suggesting a possible upside of 16.4%. Robert W. Baird has the highest price target set, predicting ZBH will reach $172.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $120.00 for Zimmer Biomet in the next year.
View the latest price targets for ZBH.
What is the current consensus analyst rating for Zimmer Biomet?: Zimmer Biomet currently has 1 sell rating, 9 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ZBH, but not buy more shares or sell existing shares.
View the latest ratings for ZBH.
What other companies compete with Zimmer Biomet?: Other companies that are similar to Zimmer Biomet include Align Technology, Smith & Nephew, Edwards Lifesciences, Cardinal Health and ICON Public. Learn More about companies similar to Zimmer Biomet.
How do I contact Zimmer Biomet's investor relations team?: Zimmer Biomet's physical mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider's listed phone number is (574) 267-6131 and its investor relations email address is [email protected]. The official website for Zimmer Biomet is www.zimmerbiomet.com. Learn More about contacing Zimmer Biomet investor relations.

Zimmer Biomet - ZBH Stock Price Target and Predictions

Analyst Price Target for ZBH

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

1.20 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Zimmer Biomet?

What is the current price target for Zimmer Biomet?

What is the current consensus analyst rating for Zimmer Biomet?

What other companies compete with Zimmer Biomet?

How do I contact Zimmer Biomet's investor relations team?